KEYNOTE-170: Phase 2 study of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL) or relapsed or refractory Richter syndrome (rrRS)
Titel:
KEYNOTE-170: Phase 2 study of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL) or relapsed or refractory Richter syndrome (rrRS)
Auteur:
Michot, J.-M. Armand, P. Ding, W. Ribrag, V. Christian, B. Marinello, P. Chlosta, S. Zhang, Y. Shipp, M. Zinzani, P.L.